Mallinckrodt to pay $260M for False Claims Act violations


Pharmaceutical company Mallinckrodt agreed to pay approximately $260 million as part of a settlement announced by the Department of Justice for underpaying Medicaid rebates and violating kickback laws regarding its drug Acthar.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.